Literature DB >> 7725892

The use of non-medical/alternative treatment in multiple sclerosis. A 5 year follow-up study.

E Stenager1, E N Stenager, L Knudsen, K Jensen.   

Abstract

Forty-nine patients (22 males, 27 females) were examined and interviewed with 5 years interval in order to determine the extent of the use of non-medical (alternative) treatment and whether the use influenced the natural course of multiple sclerosis (MS). Using clinical course, Kurtzke Disability Status scale, bladder and bowel function, neuropsychological tests, psychological tests, divorce and self-assessment score as parameters, it was found that non-medical treatment did not alter the course of MS. To confirm this result a clinical trial in a controlled design is needed. The use of non-medical treatment declined over the 5 years from 55% to 27%. The use of non-medical treatment could be interpreted as an indicator of psycho-social difficulties in MS patients.

Entities:  

Mesh:

Year:  1995        PMID: 7725892

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  5 in total

Review 1.  Complementary and alternative medicine and coping in neuroimmunological diseases.

Authors:  A Apel; B Greim; U K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

2.  Sexual function in multiple sclerosis. A 5-year follow-up study.

Authors:  E Stenager; E N Stenager; K Jensen
Journal:  Ital J Neurol Sci       Date:  1996-02

3.  Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study.

Authors:  E Stenager; L Knudsen; K Jensen
Journal:  Ital J Neurol Sci       Date:  1995-12

Review 4.  Complementary and alternative medicine in multiple sclerosis.

Authors:  Annett Apel-Neu; U K Zettl
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

5.  Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.

Authors:  Paulus S Rommer; Nicolaus König; Annett Sühnel; Uwe K Zettl
Journal:  CNS Neurosci Ther       Date:  2018-04-10       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.